CVALF (Covalon Technologies) Buyback Yield %: 0.00 (As of Jul. 09, 2026)


CVALF Covalon Technologies Ltd CVALF
83 GF Score
Price $1.51
GF Value $1.53
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies Buyback Yield %?

Covalon Technologies CVALF -1.79% 83 Buyback Yield % is 0.00 as of Jul. 09, 2026. GuruFocus rates CVALF with a GF Score™ of 83/100 and a GF Value™ of $1.53 (Fairly Valued). The stock has 2 warning signs investors should review. Among 346 Medical Devices & Instruments companies, Covalon Technologies ranks worse than 289017.05% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Covalon Technologies's current buyback yield was 0.00%.


Covalon Technologies Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Covalon Technologies's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies Buyback Yield % Chart

Covalon Technologies Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 2.80 4.36 0.00 0.00

Covalon Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CVALF vs ISRG, BDX, MDLN: Buyback Yield % Comparison

For the Medical Instruments & Supplies subindustry, Covalon Technologies's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Covalon Technologies's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Buyback Yield % falls into.


CVALF
83GF Score
Covalon Technologies Ltd CVALF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Covalon Technologies Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Covalon Technologies's Buyback Yield for the fiscal year that ended in Sep. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 41.81245
=0.00%

Covalon Technologies's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 35.9034
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Covalon Technologies (CVALF) has a Buyback Yield % of 0.00 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Covalon Technologies and its competitors. According to the industry distribution chart, Covalon Technologies ranks #999999 out of 346 companies in the Medical Devices & Instruments industry.
Is Covalon Technologies' Buyback Yield % too high?
Covalon Technologies' current Buyback Yield % is 0.00. Based on the distribution chart, Covalon Technologies ranks #999999 out of 346 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Covalon Technologies has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Buyback Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Covalon Technologies ranks #999999 out of 346 companies for Buyback Yield %. This places Covalon Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Covalon Technologies and its competitors. Covalon Technologies's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.53, compared to a current price of $1.51 — trading 1.3% below its estimated fair value. The current Buyback Yield % is 0.00. Covalon Technologies' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Buyback Yield % is 0.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be undervalued. The current stock price of $1.51 is trading 1.3% below its estimated GF Value™ of $1.53. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • Buyback Yield %: 0.00
  • GF Value™: $1.53 vs. price of $1.51 (1.3% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
83GF Score

Get the complete analysis for CVALF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.51
Price
$1.53
GF Value